Taken together, our findings reveal that in prostate cancer cells, GALNT7 can modify the O-glycosylation of both cell surface proteins and proteins in the secretory pathway, leading to upregulation of the Tn antigen, which is a hallmark of cancer and involved in tumor progression and metastasis [38]. This evidence concerns the gene GALNT7 and prostate carcinoma.